TickerFacts.

Allarity Therapeutics, Inc. (ALLR): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$14.83M
Year ended 2025-12-31
-$13.78M
Trailing 12 months to 2026-06-30
2020-12-31: -$7.25M2022-12-31: -$16.84M2023-12-31: -$12.74M2024-12-31: -$17.65M2025-12-31: -$14.83M-$14.83M
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$14.83Mn/m2026-03-30, From 2025-01-01
2024-12-31-$17.65Mn/m2026-03-30, From 2024-01-01
2023-12-31-$12.74Mn/m2025-03-31, From 2023-01-01
2022-12-31-$16.84Mn/a2024-03-08, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31-$7.25Mn/a2022-05-17, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Allarity Therapeutics, Inc. (ALLR)2025-12-31-$14.83Mn/m
Can-Fite BioPharma Ltd. (CANF)2025-12-31-$8.95Mn/m
Medicinova Inc (MNOV)2025-12-31-$9.81Mn/m
Scienture Holdings, Inc. (SCNX)2024-12-31-$14.28Mn/a
Mereo BioPharma Group plc (MREO)2025-12-31-$30.99Mn/m
Clene Inc. (CLNN)2025-12-31-$18.59Mn/m
Quantum Cyber N.V. (QUCY)2025-12-31-$10.98Mn/m
Silence Therapeutics plc (SLN)2025-12-31-$62.33Mn/m
Yarrow Bioscience, Inc. (YARW)2025-12-31-$33.12Mn/m

Compare ALLR, CANF, MNOV, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗